These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29952049)

  • 1. Empirical validation of the reverse parametric waiting time distribution and standard methods to estimate prescription durations for warfarin.
    Thrane JM; Støvring H; Hellfritzsch M; Hallas J; Pottegård A
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1011-1018. PubMed ID: 29952049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining estimates of prescription durations by using observed covariates in pharmacoepidemiological databases: an application of the reverse waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):900-908. PubMed ID: 28466973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling.
    Bødkergaard K; Selmer RM; Hallas J; Kjerpeseth LJ; Pottegård A; Skovlund E; Støvring H
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1072-1078. PubMed ID: 32436295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining prescription durations based on the parametric waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1451-1459. PubMed ID: 27670969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using multiple random index dates with the reverse waiting time distribution improves precision of estimated prescription durations.
    Bødkergaard K; Selmer RM; Hallas J; Kjerpeseth LJ; Skovlund E; Støvring H
    Pharmacoepidemiol Drug Saf; 2021 Dec; 30(12):1727-1734. PubMed ID: 34382713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating medication stopping fraction and real-time prevalence of drug use in pharmaco-epidemiologic databases. An application of the reverse waiting time distribution.
    Støvring H; Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):909-916. PubMed ID: 28474439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of methods approximating drug prescription durations in claims data: modeling, simulation, and application to real data.
    Meid AD; Heider D; Adler JB; Quinzler R; Brenner H; Günster C; König HH; Haefeli WE
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1434-1442. PubMed ID: 27633276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological challenges in assessment of current use of warfarin among patients with atrial fibrillation using dispensation data from administrative health care databases.
    Sinyavskaya L; Matteau A; Johnson S; Durand M
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):979-986. PubMed ID: 29869382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A probabilistic bias analysis for misclassified categorical exposures, with application to oral anti-hyperglycaemic drugs.
    Arfè A; Nicotra F; Ghirardi A; Simonetti M; Lapi F; Sturkenboom M; Corrao G
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1443-1450. PubMed ID: 27594547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assigning exposure duration to single prescriptions by use of the waiting time distribution.
    Pottegård A; Hallas J
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):803-9. PubMed ID: 23703741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring drug exposure: concordance between defined daily dose and days' supply depended on drug class.
    Sinnott SJ; Polinski JM; Byrne S; Gagne JJ
    J Clin Epidemiol; 2016 Jan; 69():107-13. PubMed ID: 26146090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting prolonged dose titration in patients starting warfarin.
    Finkelman BS; French B; Bershaw L; Brensinger CM; Streiff MB; Epstein AE; Kimmel SE
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1228-1235. PubMed ID: 27456080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the effect of current, previous and never use of drugs in studies based on prescription registries.
    Nielsen LH; Løkkegaard E; Andreasen AH; Hundrup YA; Keiding N
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):147-53. PubMed ID: 19072775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.
    Grzymala-Lubanski B; Själander S; Renlund H; Svensson PJ; Själander A
    Thromb Res; 2013 Feb; 131(2):130-4. PubMed ID: 23232091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.
    Halvorsen S; Ghanima W; Fride Tvete I; Hoxmark C; Falck P; Solli O; Jonasson C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):28-36. PubMed ID: 27680880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Random Effects Warfarin Days' Supply (REWarDS) Model: Development and Validation of a Novel Method for Estimating Exposure to Warfarin Using Administrative Data.
    Salmasi S; Högg T; Safari A; De Vera MA; Lynd LD; Koehoorn M; Barry AR; Andrade JG; Loewen P
    Am J Epidemiol; 2022 May; 191(6):1116-1124. PubMed ID: 35015808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of patient-reported warfarin dose in a prospective incident cohort study.
    Dumas S; Rouleau-Mailloux E; Barhdadi A; Talajic M; Tardif JC; Dubé MP; Perreault S
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):285-9. PubMed ID: 24458454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study.
    Hellfritzsch M; Rathe J; Stage TB; Thirstrup S; Grove EL; Damkier P; Pottegård A
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):336-43. PubMed ID: 26696392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.